CAPITOL HILL CONSULTING GROUP

Lobbying for BYHEART, INC. · Infant Formulat Manufacturer

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New York · House · Senate · $50,000.00 income · posted Jul 20, 2026

Lobbying activity 3

Manufacturing

Infant Formula Safety, Nutrition, Innovation, and Manufacturing.

Health Issues

Infant Formula Safety, Nutrition, Innovation, and Manufacturing.

Food Industry (safety, labeling, etc.)

Infant Formula Safety, Nutrition, Innovation, and Manufacturing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.